The Mount Sinai Alcoholic Liver Disease Research Center aims to elucidate the pathogenesis of alcoholic liver injury and fibrosis due to oxidant stress. Read More
Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration
May 22, 2013 - Partnership will accelerate the pace of discovery and innovation in Biomedical Sciences.
Ketamine Shows Significant Benefit in People with Treatment-Resistant Depression
May 20, 2013 - Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic.